4/A//SEC Filing
KYTO BIOPHARMA INC 4/A
Accession 0001354488-10-002899
CIK 0001164888operating
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 11:25 AM ET
Size
12.8 KB
Accession
0001354488-10-002899
Insider Transaction Report
Form 4/AAmended
Credifinance Capital Corp.
10% Owner
Transactions
- Other
Convertible Preferred
2010-09-02−473,674→ 473,674 totalExercise: $0.45From: 2010-09-14Exp: 2010-09-14→ Common (473,674 underlying) - Other
Common Stock
2010-09-02−8,431,065→ 8,983,219 total
Holdings
- 473,674(indirect: Joint Filing)
Convertible Preferred
Exercise: $0.45From: 2010-09-14Exp: 2010-09-14→ Common (473,674 underlying) - 8,983,219(indirect: Joint Filing)
Common Stock
BENARROCH GEORGES
DirectorPresident
Transactions
- Other
Common Stock
2010-09-02−8,431,065→ 8,983,219 total - Other
Convertible Preferred
2010-09-02−473,674→ 473,674 totalExercise: $0.45From: 2010-09-14Exp: 2010-09-14→ Common (473,674 underlying)
Holdings
- 8,983,219(indirect: Joint Filing)
Common Stock
- 473,674(indirect: Joint Filing)
Convertible Preferred
Exercise: $0.45From: 2010-09-14Exp: 2010-09-14→ Common (473,674 underlying)
Footnotes (4)
- [F1]This is to report the pledge of 8,431,065 common shares owned by Credifinance Capital Corp to a corporate lender to secure indebtedness. This is reported on advice of counsel because the pledge of shares grants dispositive power to the lender, who may dispose of shares without further consent of owner in the event of default on the underlying indebtedness
- [F2]This is to report the pledge of 8,431,065 common shares and 473,674 convertible preferred shares owned by Credifinance Capital Corp to a corporate lender to secure indebtedness. Georges Benarroch, President and Director of the issuer, is an officer and director of Credifinance Capital Corp and responsible for day to day operations. He disclaims beneficial ownership in securities held by Credifinance Capital Corp.
- [F3]Form 4 Joint Filer Information: Georges Benarroch Address 49 Ave Foch Paris 75116 Designated Filer Credifinance Capital Corp. Issuer and Ticker Symbol: Kyto BioPharma Inc. (KBPH) Date of Event Requiring Statement: September 2, 2010 Relationship of Reporting Person to Issuer: Director, Officer: President Signature /s/ Georges Benarroch
- [F4]This is to report the pledge of 473,674 convertible preferred shares owned by Credifinance Capital Corp to a corporate lender to secure indebtedness. This is reported on advice of counsel because the pledge of shares grants dispositive power to the lender, who may dispose of shares without further consent of owner in the event of default on the underlying indebtedness
Documents
Issuer
KYTO BIOPHARMA INC
CIK 0001164888
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001164888
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 11:25 AM ET
- Size
- 12.8 KB